EM, N., HA, E., BMMA, E. n., HM, E., HG, K., S, S., . . . EES, M. (2022). Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome. Dove Medical Press.
Chicago Style (17th ed.) CitationEM, Nassef, Elabd HA, El nagger BMMA, Elzomor HM, Kotb HG, Sabry S, Zaghloul BA, Hassan AS, and Mohamed EES. Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome. Dove Medical Press, 2022.
MLA (9th ed.) CitationEM, Nassef, et al. Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.